Page last updated: 2024-09-04

abiraterone and Angiogenesis, Pathologic

abiraterone has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouchaert, P; Branchereau, J; De La Taille, A; Lebdai, S; Robert, G	1
Petrylak, DP	1

Reviews

2 review(s) available for abiraterone and Angiogenesis, Pathologic

Article	Year
[Corticotherapy in castration-resistant prostate cancer]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23 Suppl 1 Topics: Androstenes; Androstenols; Antineoplastic Agents; Apoptosis; Clinical Trials as Topic; Drug Therapy, Combination; Glucocorticoids; Humans; Inflammation; Male; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Glucocorticoid; Survival Analysis; Treatment Outcome	2013
Current clinical trials in castrate-resistant prostate cancer. Current urology reports, 2011, Volume: 12, Issue:3 Topics: Androstenes; Androstenols; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Male; Neoplasm Staging; Neovascularization, Pathologic; Nitriles; Phenylthiohydantoin; Prednisone; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids; Tissue Extracts; Treatment Outcome	2011

Article

Year

[Corticotherapy in castration-resistant prostate cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23 Suppl 1

Topics: Androstenes; Androstenols; Antineoplastic Agents; Apoptosis; Clinical Trials as Topic; Drug Therapy, Combination; Glucocorticoids; Humans; Inflammation; Male; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Glucocorticoid; Survival Analysis; Treatment Outcome

2013

Current clinical trials in castrate-resistant prostate cancer.

Current urology reports, 2011, Volume: 12, Issue:3

Topics: Androstenes; Androstenols; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Male; Neoplasm Staging; Neovascularization, Pathologic; Nitriles; Phenylthiohydantoin; Prednisone; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids; Tissue Extracts; Treatment Outcome

2011